Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Liver transplantation for type I glycogen storage disease.

Literature DB >> 6133106

Liver transplantation for type I glycogen storage disease.

J J Malatack, D N Finegold, S Iwatsuki, B W Shaw, J C Gartner, B J Zitelli, T Roe, T E Starzl.

Abstract

Mesh：

Substances：
Glucose-6-Phosphatase

Year: 1983 PMID： 6133106 PMCID： PMC3022514 DOI： 10.1016/s0140-6736(83)91910-4

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

× No keyword cloud information.

14 in total

1. CHANGE IN SERUM HAPTOGLOBIN TYPE FOLLOWING HUMAN LIVER TRANSPLANTATION.

Authors: D A MERRILL; C H KIRKPATRICK; W E WILSON; C M RILEY
Journal: Proc Soc Exp Biol Med Date: 1964-07

2. THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS.

Authors: T E STARZL; T L MARCHIORO; A W SEXTON; B ILLINGWORTH; W R WADDELL; T D FARIS; T J HERRMANN
Journal: Surgery Date: 1965-05 Impact factor: 3.982

3. Glucose-6-phosphatase of the liver in glycogen storage disease.

Authors: G T CORI; C F CORI
Journal: J Biol Chem Date: 1952-12 Impact factor: 5.157

4. Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans.

Authors: N Kashiwagi; C G Groth; T E Starzl
Journal: Proc Soc Exp Biol Med Date: 1968-05

5. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.

Authors: H L Greene; A E Slonim; J A O'Neill; I M Burr
Journal: N Engl J Med Date: 1976-02-19 Impact factor: 91.245

Review 6. Evolution of liver transplantation.

Authors: T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal: Hepatology Date: 1982 Sep-Oct Impact factor: 17.425

7. Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, alpha 1-antitrypsin, C8, and factor B.

Authors: C A Alper; D Raum; Z L Awdeh; B H Petersen; P D Taylor; T E Starzl
Journal: Clin Immunol Immunopathol Date: 1980-05

8. Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery.

Authors: J Folkman; A Philippart; W J Tze; J Crigler
Journal: Surgery Date: 1972-08 Impact factor: 3.982

9. Human C'3: evidence for the liver as the primary site of synthesis.

Authors: C A Alper; A M Johnson; A G Birtch; F D Moore
Journal: Science Date: 1969-01-17 Impact factor: 47.728

10. Synthesis of human plasminogen by the liver.

Authors: D Raum; D Marcus; C A Alper; R Levey; P D Taylor; T E Starzl
Journal: Science Date: 1980-05-30 Impact factor: 47.728

21 in total

Review 1. Enzyme-replacement therapy: problems and prospects.

Authors: B Rademaker; J Raber
Journal: Pharm Weekbl Sci Date: 1989-10-20

2. Distal splenorenal shunt for portal vein thrombosis after liver transplantation.

Authors: I R Marino; C O Esquivel; A B Zajko; J Malatack; V P Scantlebury; B W Shaw; T E Starzl
Journal: Am J Gastroenterol Date: 1989-01 Impact factor: 10.864

3. The mother lode of liver transplantation, with particular reference to our new journal.

Authors: T E Starzl
Journal: Liver Transpl Surg Date: 1998-01

4. Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation.

Authors: J C Gartner; I Bergman; J J Malatack; B J Zitelli; R Jaffe; J B Watkins; B W Shaw; S Iwatsuki; T E Starzl
Journal: Pediatrics Date: 1986-01 Impact factor: 7.124

Review 5. Liver transplantation (1).

Authors: T E Starzl; A J Demetris; D Van Thiel
Journal: N Engl J Med Date: 1989-10-12 Impact factor: 91.245

Review 10. Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors: P Cochat; K Schärer
Journal: Pediatr Nephrol Date: 1993-04 Impact factor: 3.714